UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

Frontiers in pharmacology, 2019-02, Vol.10, p.99-99

2019

Volltextzugriff (PDF)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors

Frontiers in pharmacology, 2021-10, Vol.12, p.749692-749692

2021

Volltextzugriff (PDF)

Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing

CPT: pharmacometrics and systems pharmacology, 2023-12, Vol.12 (12), p.1827-1845

2023

Volltextzugriff (PDF)

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications

Frontiers in pharmacology, 2022-02, Vol.13, p.833217-833217

2022

Volltextzugriff (PDF)

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations

Journal of personalized medicine, 2021-06, Vol.11 (7), p.615

2021

Volltextzugriff (PDF)

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org

Clinical and translational science, 2023-11, Vol.16 (11), p.2130-2143

2023

Volltextzugriff (PDF)

Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing

Therapeutic drug monitoring, 2023-04, Vol.45 (2), p.143-150

2023

Volltextzugriff (PDF)

84 Using Opportunistic Sampling and Remnant Blood Samples to Develop Pediatric Pharmacokinetic Models to Inform Antidepressant Dosing

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.22-23

2024

Volltextzugriff (PDF)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial

Journal of personalized medicine, 2021-11, Vol.11 (11), p.1188

2021

Volltextzugriff (PDF)

Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents

Pharmacotherapy, 2023-07, Vol.43 (7), p.675-690

2023

Volltextzugriff (PDF)

Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study

The journal of clinical psychiatry, 2020-08, Vol.81 (5)

2020

Volltextzugriff (PDF)

CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study

Journal of child and adolescent psychopharmacology, 2019-06, Vol.29 (5), p.340-347

2019

Volltextzugriff (PDF)

Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients

Clinical pharmacokinetics, 2023-11, Vol.62 (11), p.1621-1637

2023

Volltextzugriff (PDF)

Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents

Clinical pharmacology and therapeutics, 2024-04, Vol.115 (4), p.860-870

2024

Volltextzugriff (PDF)

Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents

Journal of child and adolescent psychopharmacology, 2024-02, Vol.34 (1), p.34-41

2024

Volltextzugriff (PDF)

Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders

Journal of child and adolescent psychopharmacology, 2019-06, Vol.29 (5), p.348-361

2019

Volltextzugriff (PDF)

Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents

Journal of child and adolescent psychopharmacology, 2024-02, Vol.34 (1), p.67-69

2024

Volltextzugriff (PDF)

Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders

Pharmacopsychiatry, 2022-05, Vol.55 (3), p.139-147

2022

Volltextzugriff (PDF)

A retrospective examination of adjunctive L-methylfolate in children and adolescents with unipolar depression

Journal of affective disorders, 2022-09, Vol.312, p.315-321

2022

Volltextzugriff (PDF)

Cariprazine in Youth with Bipolar and Psychotic Disorders: A Retrospective Chart Review

Journal of child and adolescent psychopharmacology, 2020-05, Vol.30 (4), p.267-272

2020

Volltextzugriff (PDF)

The Influence of Pharmacodynamic Genes on Fluoxetine Response in Pediatric Anxiety and Depressive Disorders

Journal of child and adolescent psychopharmacology, 2020-05, Vol.30 (4), p.276-277

2020

Volltextzugriff (PDF)

19.3 Designer Genes: Tailoring Antidepressant Treatment in Youth Using All Available Threads of Evidence

Journal of the American Academy of Child and Adolescent Psychiatry, 2024-10, Vol.63 (10), p.S340-S340

2024

Volltextzugriff (PDF)

2.37 Patterns of Antidepressant Adherence in Youth With Anxiety Disorders: A Prospective Study Using Electronic Monitoring

Journal of the American Academy of Child and Adolescent Psychiatry, 2024-10, Vol.63 (10), p.S195-S195

2024

Volltextzugriff (PDF)

2.34 Variability in Sertraline Pharmacokinetics Explained By CYP2C19 and CYP2B6

Journal of the American Academy of Child and Adolescent Psychiatry, 2024-10, Vol.63 (10), p.S194-S194

2024

Volltextzugriff (PDF)

2.53 CYP2D6 Metabolizer Phenotype Predicts Aripiprazole Pharmacokinetics in Children and Adolescents

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-10, Vol.62 (10), p.S197-S197

2023

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors

Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org

Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing

84 Using Opportunistic Sampling and Remnant Blood Samples to Develop Pediatric Pharmacokinetic Models to Inform Antidepressant Dosing

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial

Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents

Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study

CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study

Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients

Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents

Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents

Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders

Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents

Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders

A retrospective examination of adjunctive L-methylfolate in children and adolescents with unipolar depression

Cariprazine in Youth with Bipolar and Psychotic Disorders: A Retrospective Chart Review

The Influence of Pharmacodynamic Genes on Fluoxetine Response in Pediatric Anxiety and Depressive Disorders

19.3 Designer Genes: Tailoring Antidepressant Treatment in Youth Using All Available Threads of Evidence

2.37 Patterns of Antidepressant Adherence in Youth With Anxiety Disorders: A Prospective Study Using Electronic Monitoring

2.34 Variability in Sertraline Pharmacokinetics Explained By CYP2C19 and CYP2B6

2.53 CYP2D6 Metabolizer Phenotype Predicts Aripiprazole Pharmacokinetics in Children and Adolescents

Suchergebnisse filtern